The way to serotonergic use and abuse in migraine

International Journal of Clinical Pharmacology Research

Volumn 17, Issue 2-3, 1997, Pages 79-84

  Nicolodi, M ^a,b   Del Bianco, P L ^a   Sicuteri, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Interuniv Ctr Neurochem Clin P   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE; METHYSERGIDE; PROPRANOLOL; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN;

ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG USE; FEMALE; HUMAN; IMPOTENCE; LEG PAIN; LIBIDO; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR UPREGULATION; SOMNOLENCE; STOMACH PAIN;

ADULT; BEHAVIOR; DOUBLE-BLIND METHOD; ERGOTAMINE; FEMALE; HUMANS; MALE; METHYSERGIDE; MIDDLE AGED; MIGRAINE DISORDERS; PROPRANOLOL; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0031370970     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sicuteri F., Anselmi B., Fanciullacci M. The serotonin theory of migraine. In: Bonica J.J., Albe-Fessard D., eds. Adv. in Neurol., Vol. 4. Raven Press, New York, 1974, pp. 383-394.
2. Nicolodi M., Sicuteri F. Links between headache mechanisms and new medications Cl n J. Pain, 7. 64-71. 1991.
3. Del Bianco P.L., Sicuteri F. Computerized venospasm a method for exploring the neurovascular junction in man. J. Pharmacol Method., 1, 329-340. 1978.
4. Klawans H.L., D'Amico D.J., Patel B.C. Behavioral super-sensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Psychopharmacology, 44, 279-300, 1975.
5. Fanciullacci M., Franchi G., Sicuteri F. Ergotamine and methysergide as serotonin partial agonists in migraine. Headache, 16,226-231, 1976.
6. McCarthy B.G., Peroutka S.J. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache. 29, 420-422, 1989.
7. Maura G., Raiteri M. Functional evidence that chronic drugs induce adaptative changes of central autoreceptors regulating serotonin release. Eur. J. Pharmacol., 97, 309-13, 1984
8. Middelmiss D.N., Blakeborough L., Leather S.R. Direct evidence for an interaction of adrenergic blockers with 5-HT receptor. Nature, 267, 289. 1977.
9. Stolz J.F, Marsden C.A. Withdrawal from chronic treatment with metergoline, propranolol and amitryptiline enhances serotonin receptor mediated behavior in the rat. Eur J. Pharmacol. 79, 17-22, 1982.
10. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8 (suppl 8), 1-96, 1988.
11. Saxena P.R., Cairo-Rawlins W.I. Presynaptic inhibition by ergotamine of the response to cardioaccelerator nerve stimulation in the cat. Eur. J. Pharmacol., 58, 305, 1979.
12. Berde B., Schild H.O, Ergot alkaloids and related compounds. Handbook of Experimental Pharmacology, Vol. 49. Springer-Verlag, Berlin, 1978.
13. Roquebert J., Grenié B. α2-Adrenergic agonist and α1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats. Arch. Int. Pharmacodyn., 284, 30, 1986.
14. Panconesi A. et al. Reduced serotonin vascular sensitivity in ergotamine abusers. Cephalalgia, 9, 259-264, 1989
15. Franchi G. On the circulatory collapse from ergotamine during migraine attack: a clinical pharmacological contribution In: Savoldi F., Nappi G., ecs. "Headache" Fid a. Abano (Padua), 1979, pp. 240-244.
16. Sicuter F., Nicolodi M., Fusco B. Abnormal sensitivity to neurotransmitters agonists, antagonists and neurotransmitter releasers. In: Olesen J., Edvinsson L., eds. "Basic mechanism of headache" Elsevier Science Publ., Amsterdam, london 1988. pp. 276-286.
17. Zung W.W. A self-rating depression scale. Arch. Gen. Psychiatry, 2. 63-70, 1965.
18. Nicolodi M., Sicuteri F., Bartolini A., Ghelarcini C., Coppola G. Sumatnptan: central actions in animals and in man. In Clifford Rose F., ed. Advances in Headache Research, Vol. 4 Smith-Gordon, london, 1994, pp. 183-188
19. Ghelardini C. et al. The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatnptan. J. Pharm. Exper. Ther., 1996(in press).
20. Williams M. Scale for the measurement of memory. Br. J. Soc. Clin. Psychol., 7, 19-34, 1986.
21. Kennett G.A., Dourish C.T., Cu'zon G. 5-HT1B agonists induce anorexia at a postsynaptic site. Eur. J. Pharmacol., 141, 429-435, 1987.
22. Carli M., Tatarcynska E., Cervo I., Samanin R. Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolitic-like but not antidepressant-like effect in the rat. Eur. J. Pharmacol., 234, 215-221, 1993.
23. Tomimaga K . Shibata S., Ueki S., Watanabe S. Effects of 5-HT1A receptor antagonists on the circactian rhythm of wheel-running activity in the hamster Eur. J. Pharmacol., 214, 79-84,1992.
24. Del Bianco P.L., Franchi G., Anselmi B., Sicuteri F. Monoamine supersensitivity of smooth muscle in vivo in nociceptive disorders In: Critch:ey M. et al., eds Advan. in Neurol., Vol. 33. Raven Press, New York. 1982, pp. 381-387.
25. Rodgers R.J., Shepherd J.K., Donat P. Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice. Neurosci Biobehav. Rev (United States), 15, 489-495, 1991.
26. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonist studies with microdialysis. Eur. J. Pharmacol., 200, 1-8, 1991.